Larimar Therapeutics
Octavia Kane, MBA, is an experienced Human Resources professional currently serving as the Human Resources Director at Larimar Therapeutics Inc. since August 2024. Prior to this role, Octavia held the position of Director, Human Resources Business Partner at SwanBio Therapeutics from November 2021 to June 2024, where key responsibilities included managing end-to-end HR services and leading change management initiatives. With prior roles at Saint-Gobain and First Quality Enterprises, Octavia has a strong background in talent acquisition, employee relations, and organizational restructuring. Educational qualifications include a Bachelor of Arts in Psychology and an MBA with a concentration in Human Resources from Bryn Mawr College and the Fox School of Business at Temple University, respectively.
This person is not in any teams
Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in the Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease.